Immix Biopharma, Inc. (IMMX) KPIs and segments

IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30

$7.84−0.23 (-2.85%)

Close on Nov 13, 2026Market cap $560.87MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Immix Biopharma's business

Coming soon

This tab will track the numbers specific to Immix Biopharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?